Related Experiment Videos
[Concomitant surgery--coronary artery bypass and pulmonary lobectomy]
1Dept. of Cardiothoracic Surgery, Hadassah University Hospital, Jerusalem.
Harefuah
|July 7, 2000
Summary
Combined coronary artery bypass grafting and pulmonary lobectomy is a safe and effective treatment for patients with both coronary artery disease and lung cancer. This combined approach reduces patient suffering and healthcare costs compared to separate procedures.
Area of Science:
- Cardiovascular Surgery
- Thoracic Oncology
- Cardiopulmonary Medicine
Background:
- Coronary artery disease (CAD) and resectable lung cancer are significant causes of patient morbidity and mortality.
- Percutaneous coronary interventions and coronary artery bypass grafting are common treatments for CAD.
- Surgical resection is the primary treatment for resectable lung cancer.
Observation:
- This study reports on 3 patients (two men aged 64 and 66, one woman aged 77) with both significant CAD and resectable lung tumors.
- All 3 patients successfully underwent combined coronary artery bypass grafting (CABG) and pulmonary lobectomy.
- The combined surgical approach was well-tolerated by all patients.
Findings:
- Concomitant CABG and pulmonary lobectomy is a safe and effective treatment strategy.
- This combined surgical approach can decrease patient suffering.
- Performing these procedures simultaneously reduces the overall cost associated with two separate invasive interventions.
Implications:
- Combined surgical procedures can be considered for patients with concurrent CAD and lung cancer.
- This approach offers a potentially more efficient and cost-effective treatment pathway.
- Further research into optimizing combined surgical strategies for complex cardiopulmonary conditions is warranted.